Bailey Bostelman, Director, Chapter Engagement, East
We are actively recruiting leadership in the Charlotte chapter! For more information, please reach out to Bailey Bostelman at BBostelman@FightingBlindness.org.
The Strength of the Foundation is Through Our Communities
The Foundation Fighting Blindness Chapter network brings people together across the country to join in fighting blinding retinal diseases. Our family of volunteers and leaders stand up for those impacted by blinding diseases. From day one, they share the latest research and advancements, and provide access to local resources to guide individuals through their personal journey. And together, they celebrate the Foundation’s mission.
We are winning thanks to the dedication of our Chapters focusing on three key areas: education, resources, and revenue. Through informative sessions, Foundation staff, community, and national experts provide research information, low vision resources, and outreach to our local retinal specialists and eye care professionals. To continue accelerating our mission, each community is invited to be a stakeholder by participating in our fundraising events.
The Foundation Fighting Blindness Chapter Vision
Our vision is to bring a community together to end blinding diseases.
Charlotte Chapter Leadership
|Brett Schmidt||Chapter President|
|Jared Hallman||Resource Chair|
|Meghan Grom||Education Chair|
Director, Chapter Engagement, East
Since its inception in the Spring of 2006, VisionWalk has raised over $62 million to fund sight-saving research. Join your VisionWalk community! Together, we step closer to fighting blinding diseases.
Join us for Taste of the Town on Thursday, November 3, 2022 at the Rickhouse, overlooking the famed Durham Athletic Park, the original home of the Durham Bulls!
The 90-minute national webinar will feature guest presentations on emerging gene therapies from Opus, a potential anti-oxidative treatment from Nacuity, and a promising cell-based treatment from OkuloVision. The panel will answer questions from the audience on a wide range of research, clinical, and therapy development topics.